• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

opana

  1. PAR South Will Be Sold Off

    PAR South to be sold off. At least that's what it's looking like for everyone down in Alabama. Executive leadership does not understand how to handle high volume products. They fired a sales force to protect the ones at the PAR North facilities and volume is down 60% on every product. That...